StockData

Drugs Made In America Acquisition Corp. (DMAA) stock

DMAANasdaqBlank ChecksFiscal year ends December 31Also trades as DMAAR, DMAAU
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$10.90+0.00 (0.00%)

Close on Nov 16, 2026Market cap $264.62MP/E –Yield –

Drugs Made In America Acquisition EPS

Diluted earnings per share is net income divided by the share count including options and convertible securities.

No eps figures for Drugs Made In America Acquisition

Drugs Made In America Acquisition has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Drugs Made In America Acquisition figures

See a number that looks wrong?